Should You Buy Aptevo Therapeutics Inc (APVO) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/23
Aptevo Therapeutics Inc (APVO) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are mixed, with bearish moving averages and neutral RSI. The lack of significant positive news, weak financial performance, and no strong trading signals suggest a cautious approach. Holding or seeking alternative investments may be more prudent.
Technical Analysis
The MACD histogram is positive at 0.467, indicating potential bullish momentum, but the RSI at 35.307 is neutral. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key resistance levels. The price trend suggests a 50% chance of slight movement (-1.08% next day, +1.22% next week, +2.81% next month).